Finance

Lists
Q3 2026 earnings • released • EPS beat +2.56% • Revenue beat +0.74%
See results
WAT:NYSE
Waters Corp
$457.60
+1.00%
(+4.52) 1D
$457.60
0.00% (0.00)
After hours
Closed: Nov 6, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WAT...
Open
$450.61
High
$463.90
Low
$450.61
Mkt. cap
44.96B
Avg. vol.
977.14K
Volume
695.78K
P/E ratio
114.43
52-wk high
$482.28
52-wk low
$282.77
EPS
$4.00
Beta
1.16
Shares outstanding
98.25M
No. of employees
15K
Open
$450.61
High
$463.90
Low
$450.61
Mkt. cap
44.96B
Avg. vol.
977.14K
Volume
695.78K
P/E ratio
114.43
52-wk high
$482.28
52-wk low
$282.77
EPS
$4.00
Beta
1.16
Shares outstanding
98.25M
No. of employees
15K
News stories
From web sources and news partners
Profile
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries. The company has primary manufacturing facilities in 9 U.S. locations as well as 11 international locations including Wexford, Wilmslow, Birmingham, Hüllhorst, Singapore, Bangalore, Beijing, and Shanghai. Major brands include ACQUITY UPC² / UPLC Systems and columns, Xevo mass spectrometry systems, Synapt MS / HDMS systems, Zodiac HPLC columns, XTerra HPLC columns, XBridge columns, Alliance HPLC systems, Empower chromatography software, MassLynx mass spectrometry software, Oasis sample preparation products, and NuGenesis lab management system. Its primary competitors are Agilent Technologies, Thermo Fisher Scientific, Revvity, and Danaher. Wikipedia
About Waters Corp
CEOUdit Batra
Employees15K
Founded1958
HeadquartersMilford, Massachusetts, United States
SectorHealth Care
Industry-
Websitewaters.com
Analyst ratings
Based on 16 analysts giving stock ratings to WAT in the past 3 months
Strong buy
Buy
12
Hold
4
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for WAT in the last 3 months.
Highest
Current $457.60
$536.00 (+17.13%)
Average
$495.00 (+8.17%)
Lowest
$430.00 (-6.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
‏Avantika Dhabaria‏
Bank of America Securities
Hold
Maintained
-
-
11/04/2026
David Westenberg
Piper Sandler
Buy
Maintained
$530.00
+15.8%
11/04/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$530.00
+15.8%
11/04/2026
Joanne Wuensch
Citi
Buy
Maintained
$536.00
+17.1%
11/04/2026
Dan Leonard
RBC Capital
Buy
Maintained
$525.00
+14.7%
11/03/2026
Subbu Nambi
Guggenheim
Buy
Reiterated
$490.00
+7.1%
11/03/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
$470.00
+2.7%
11/04/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
$470.00
+2.7%
11/04/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$504.00
+10.1%
11/04/2026
Unknown Analyst
KeyBanc
Buy
Maintained
$500.00
+9.3%
11/04/2026
Paul Knight
KeyBanc
Buy
Maintained
$500.00
+9.3%
11/04/2026
Luke Sergott
Barclays
Buy
Maintained
$530.00
+15.8%
11/04/2026
Eve Burstein
Bernstein
Buy
Reiterated
$450.00
-1.7%
10/19/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
$465.00
+1.6%
10/09/2026
Unknown Analyst
Jefferies
Buy
Maintained
$455.00
-0.6%
10/01/2026
Evie Koslosky
Goldman Sachs
Buy
Reiterated
$515.00
+12.5%
09/20/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
$430.00
-6%
09/14/2026
Lu Li
UBS
Buy
Upgraded
$490.00
+7.1%
09/09/2026
Doug Schenkel
UBS
Buy
Upgraded
$490.00
+7.1%
09/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$420.00
-8.2%
08/05/2026
Justin Bowers
Deutsche Bank
Hold
Reiterated
$400.00
-12.6%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$440.00
-3.8%
08/04/2026
Evan Stampler
Wells Fargo
Hold
Reiterated
$400.00
-12.6%
08/05/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$400.00
-12.6%
08/05/2026
Matt Larew
William Blair
Buy
Maintained
-
-
08/04/2026
Sidharth Sahoo
HSBC
Buy
Maintained
$435.00
-4.9%
06/03/2026
Michael Polark
Wolfe Research
Buy
Maintained
$425.00
-7.1%
06/01/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
$370.00
-19.1%
05/14/2026
Patrick B Donnelly
Citi
Buy
Reiterated
$425.00
-7.1%
04/07/2026
Tycho Peterson
Jefferies
Buy
Reiterated
$470.00
+2.7%
02/10/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$4.10 / $4.00
+2.56%beat
Revenue / Est. (USD)
1.77B / 1.75B
+0.74%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Apr 2026
Jul 2026
Oct 2026
Revenue
932.36M
1.27B
1.64B
1.77B
Cost of goods sold
362.86M
679.00M
757.00M
861.00M
Cost of revenue
362.86M
679.00M
757.00M
861.00M
Research and development expenses
46.90M
95.00M
121.00M
105.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
195.78M
305.00M
368.00M
356.00M
Operating expense
254.76M
552.00M
733.00M
705.00M
Total operating expenses
617.62M
1.23B
1.49B
1.57B
Operating income
314.74M
36.00M
155.00M
201.00M
Other non operating income
2.06M
1.00M
-
-1.00M
EBT including unusual items
264.18M
-88.00M
-141.00M
74.00M
EBT excluding unusual items
308.18M
-5.00M
100.00M
147.00M
Income tax expense
38.97M
-16.00M
-5.00M
-7.00M
Effective tax rate
14.75%
18.18%
3.55%
-9.46%
Other operating expenses
-
-
-
-
Net income
225.21M
-72.00M
-136.00M
81.00M
Net profit margin
24.16%
-5.68%
-8.27%
4.58%
Earnings per share
4.53
2.70
3.05
4.10
Interest and investment income
5.67M
6.00M
5.00M
-
Interest expense
-14.29M
-48.00M
-60.00M
-53.00M
Net interest expenses
-8.62M
-42.00M
-55.00M
-53.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
367.28M
243.00M
456.00M
501.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps